Dataset Information

Endoscopic management of recurrent cholangitis following EUS-guided choledochoduodenostomy.

ABSTRACT: Video 1Endoscopic management of recurrent cholangitis after EUS-guided choledochoduodenostomy.

SUBMITTER: Salerno R

PROVIDER: S-EPMC9108114 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Endoscopic management of recurrent cholangitis following EUS-guided choledochoduodenostomy.

Salerno Raffaele R Mezzina Nicolò N Carmagnola Stefania S Ardizzone Sandro S

VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy 20220314 5

Video 1Endoscopic management of recurrent cholangitis after EUS-guided choledochoduodenostomy. ...[more]

PMID: 35585895

Similar Datasets

Project description:Endoscopic ultrasound-guided biliary drainage (EUS-BD) can be performed entirely transgastrically (hepatogastrostomy/EUS-HG) or transduodenally (choledochoduodenostomy/EUS-CDS). It is unknown how both techniques compare. The aims of this study were to compare efficacy and safety of both techniques and identify predictors of adverse events.Consecutive jaundiced patients with distal malignant biliary obstruction who underwent EUS-BD at multiple international centers were included. Technical/clinical success, adverse events, stent complications, and survival were assessed.A total of 121 patients underwent EUS-BD (CDS 60, HG 61). Technical success was achieved in 112 (92.56 %) patients (EUS-CDS 93.3 %, EUS-HG 91.8 %, P = 0.75). Clinical success was attained in 85.5 % of patients who underwent EUS-CDS group as compared to 82.1 % of patients who underwent EUS-HG (P = 0.64). Adverse events occurred more commonly in the EUS-HG group (19.67 % vs. 13.3 %, P = 0.37). Both plastic stenting (OR 4.95, 95 %CI 1.41 - 17.38, P = 0.01) and use of non-coaxial electrocautery (OR 3.95, 95 %CI 1.16 - 13.40, P = 0.03) were independently associated with adverse events. Length of hospital stay was significantly shorter in the CDS group (5.6 days vs. 12.7 days, P < 0.001). Mean follow-up duration was 151 ± 159 days. The 1-year stent patency probability was greater in the EUS-CDS group [0.98 (95 %CI 0.76 - 0.96) vs 0.60 (95 %CI 0.35 - 0.78)] but overall patency was not significantly different. There was no difference in median survival times between the groups (P = 0.36) CONCLUSIONS: Both EUS-CDS and EUS-HG are effective and safe techniques for the treatment of distal biliary obstruction after failed ERCP. However, CDS is associated with shorter hospital stay, improved stent patency, and fewer procedure- and stent-related complications. Metallic stents should be placed whenever feasible and non-coaxial electrocautery should be avoided when possible as plastic stenting and non-coaxial electrocautery were independently associated with occurrence of adverse events.

Dataset Information

Endoscopic management of recurrent cholangitis following EUS-guided choledochoduodenostomy.

Publications

Endoscopic management of recurrent cholangitis following EUS-guided choledochoduodenostomy.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets